Terms: = Lymphoma AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
314 results:
1. Immunogenetic Background of Chronic Lymphoproliferative Disorders in Romanian Patients-Case Control Study.
Tizu M; Calenic B; Maruntelu I; Caragea AM; Talangescu A; Ursu L; Rotarescu C; Surugiu M; Constantinescu AE; Constantinescu I
Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38535155
[TBL] [Abstract] [Full Text] [Related]
2. Allogeneic CAR-T cells with of hla-a/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies.
Chen X; Tan B; Xing H; Zhao X; Ping Y; Zhang Z; Huang J; Shi X; Zhang N; Lin B; Cao W; Li X; Zhang X; Li L; Jiang Z; Zhang M; Li W; Liu M; Du B; Zhang Y
Cancer Immunol Immunother; 2024 Jan; 73(1):13. PubMed ID: 38231412
[TBL] [Abstract] [Full Text] [Related]
3. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition.
Urai S; Iguchi G; Kanie K; Bando H; Yamamoto M; Oi Y; Kashitani Y; Iida K; Kanzawa M; Fukuoka H; Takahashi M; Shintani Y; Ogawa W; Takahashi Y
Eur J Endocrinol; 2024 Jan; 190(1):K1-K7. PubMed ID: 38146732
[TBL] [Abstract] [Full Text] [Related]
4. The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
Molvi Z; Klatt MG; Dao T; Urraca J; Scheinberg DA; O'Reilly RJ
J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37775115
[TBL] [Abstract] [Full Text] [Related]
5. hla-a*02:06 allele may be susceptible to myelodysplastic syndrome in Zhejiang Han population, China.
Chen N; Wang F; Zhao Y; Dong L; Wang W; Zhang W; He J; Zhu F
Int J Immunogenet; 2023 Oct; 50(5):233-242. PubMed ID: 37485595
[TBL] [Abstract] [Full Text] [Related]
6. ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Mota I; Patrucco E; Mastini C; Mahadevan NR; Thai TC; Bergaggio E; Cheong TC; Leonardi G; Karaca-Atabay E; Campisi M; Poggio T; Menotti M; Ambrogio C; Longo DL; Klaeger S; Keshishian H; Sztupinszki ZM; Szallasi Z; Keskin DB; Duke-Cohan JS; Reinhold B; Carr SA; Wu CJ; Moynihan KD; Irvine DJ; Barbie DA; Reinherz EL; Voena C; Awad MM; Blasco RB; Chiarle R
Nat Cancer; 2023 Jul; 4(7):1016-1035. PubMed ID: 37430060
[TBL] [Abstract] [Full Text] [Related]
7. Gene expression and TCR amino acid sequences selected by hla-a02:01-restricted CTLs specific to HTLV-1 in ATL patients.
Kusuda M; Nakasone H; Yoshimura K; Okada Y; Tamaki M; Matsuoka A; Ishikawa T; Meno T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Gomyo A; Tanihara A; Kimura SI; Kako S; Kanda Y
Br J Haematol; 2023 Aug; 202(3):578-588. PubMed ID: 37317804
[TBL] [Abstract] [Full Text] [Related]
8. Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
Tanaka Y; Sato T; Yagishita N; Yamauchi J; Araya N; Aratani S; Takahashi K; Kunitomo Y; Nagasaka M; Kanda Y; Uchimaru K; Morio T; Yamano Y
Front Immunol; 2022; 13():993025. PubMed ID: 36081501
[TBL] [Abstract] [Full Text] [Related]
9. HLA homozygosity is associated with Non-Hodgkin lymphoma.
Roark CL; Ho BE; Aubrey MT; Anobile C; Israeli S; Phang TL; Braxton D; Ho AP; Freed BM
Hum Immunol; 2022 Oct; 83(10):730-735. PubMed ID: 35953408
[TBL] [Abstract] [Full Text] [Related]
10. Successful Kidney and Hematopoietic Stem Cell Transplantation for Malignant lymphoma from Different Donors: A Case Report and Literature Review.
Ono K; Ishibashi Y; Kaname S
Transplant Proc; 2022; 54(6):1589-1593. PubMed ID: 35840432
[TBL] [Abstract] [Full Text] [Related]
11. EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study.
Suolitiken D; Wang Y; Jin Z; Wang Z
Immun Inflamm Dis; 2022 Jul; 10(7):e666. PubMed ID: 35759244
[TBL] [Abstract] [Full Text] [Related]
12. A retrospective study on the clinicopathological and molecular features of 22 cases of natural killer/T-cell lymphoma in children and adolescents.
Wang GN; Zhao WG; Zhang XD; Jian XY; Zhang CL; Zhang MZ; Li WC
Sci Rep; 2022 May; 12(1):7118. PubMed ID: 35504960
[TBL] [Abstract] [Full Text] [Related]
13. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.
Marks DI; Clifton-Hadley L; Copland M; Hussain J; Menne TF; McMillan A; Moorman AV; Morley N; Okasha D; Patel B; Patrick P; Potter MN; Rowntree CJ; Kirkwood AA; Fielding AK
Lancet Haematol; 2022 Apr; 9(4):e276-e288. PubMed ID: 35358442
[TBL] [Abstract] [Full Text] [Related]
14. Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
Carvajal RD; Nathan P; Sacco JJ; Orloff M; Hernandez-Aya LF; Yang J; Luke JJ; Butler MO; Stanhope S; Collins L; McAlpine C; Holland C; Abdullah SE; Sato T
J Clin Oncol; 2022 Jun; 40(17):1939-1948. PubMed ID: 35254876
[TBL] [Abstract] [Full Text] [Related]
15. Combined impact of hla-allele matching and the CD34-positive cell dose on optimal unit selection for single-unit cord blood transplantation in adults.
Yabe T; Satake M; Odajima T; Watanabe-Okochi N; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Takanashi M; Nakajima K; Murata M; Morishima Y
Leuk Lymphoma; 2021 Nov; 62(11):2737-2746. PubMed ID: 34128753
[TBL] [Abstract] [Full Text] [Related]
16.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract] [Full Text] [Related]
17. Hematopoietic Stem Cell Transplantation From a Related Donor with Human Leukocyte Antigen 1-Antigen Mismatch in the Graft-Versus-Host Direction Using Low-dose Anti-thymocyte Globulin.
Kanda J; Ando T; Kimura SI; Fujiwara SI; Imada K; Fujisawa S; Tachibana T; Atsuta Y; Kanda Y
Cell Transplant; 2020; 29():963689720976567. PubMed ID: 33267617
[TBL] [Abstract] [Full Text] [Related]
18. Sintilimab-Induced Autoimmune Diabetes in a Patient With the Anti-tumor Effect of Partial Regression.
Wen L; Zou X; Chen Y; Bai X; Liang T
Front Immunol; 2020; 11():2076. PubMed ID: 32973816
[TBL] [Abstract] [Full Text] [Related]
19. Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas.
Polprasert C; Takeuchi Y; Makishima H; Wudhikarn K; Kakiuchi N; Tangnuntachai N; Assanasen T; Sitthi W; Muhamad H; Lawasut P; Kongkiatkamon S; Bunworasate U; Izutsu K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Yoshida K; Rojnuckarin P
Leuk Lymphoma; 2021 Jan; 62(1):95-103. PubMed ID: 32964767
[TBL] [Abstract] [Full Text] [Related]
20. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract] [Full Text] [Related]
[Next]
